Login Register Cart 0
Generic placeholder image

Current Analytical Chemistry

Editor-in-Chief

ISSN (Print): 1573-4110
ISSN (Online): 1875-6727

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Rapid Analytical Method Development and Validation for the Simultaneous Estimation of 5-Fluorouracil and Cannabidiol in Plasma and Lipid-based Nanoformulations

Author(s): Nazeer Hasan, Mohammad Imran, Dhara Jain, Athar Shamim, Sarwar Beg, Prashant Kesharwani*, Gaurav Jain and Farhan J. Ahmad*

Volume 18, Issue 7, 2022

Published on: 13 April, 2022

Page: [798 - 808] Pages: 11

DOI: 10.2174/1573411018666220304085236

Price: $65

Abstract

Background: 5-Fluorouracil (5-FU) is a well-established anticancer drug. Several studies have also demonstrated the anticancer potential of Cannabidiol (CBD) against various malignancies, including skin cancer. Reported synergistic effects of this combination fascinate researchers to consider this for the management of skin cancer.

Methods: A simple and robust HPLC method for simultaneous estimation of 5-FU and CBD at its single wavelength (237 nm) was developed and validated. The separation of these compounds was performed on Waters® HPLC system with Hypersil™ C18 RP-column using methanol and water in gradient flow as mobile phase. The method could effectively quantify the nanogram levels of both analytes simultaneously in plasma spiked samples and various nanoformulations. The analytical performance of the proposed method was validated in terms of various parameters, such as linearity, ruggedness, specificity, and few others.

Results: 5-FU as well as CBD were successfully detected at 237 nm with retention time of 1.4 and 1.84 minutes, respectively. Calibration curves were found to be linear with R2 values of 0.985 and 0.984 for 5-FU and CBD, respectively. The method was linear, precise, specific and robust. Additionally, prepared method successfully determined concentration of both drugs in combitorial nanoformulations.

Conclusion: The findings show that the developed method is simple, reliable, sensitive and economical. It could be employed for the simultaneous estimation of 5-FU and CBD in various in vitro and in vivo studies.

Keywords: 5-Fluorouracil, cannabidiol, HPLC, method validation, simultaneous estimation, nanoformulations.

« Previous Next »
Graphical Abstract

[1]
Bruni, N.; Della Pepa, C.; Oliaro-Bosso, S.; Pessione, E.; Gastaldi, D.; Dosio, F. Cannabinoid delivery systems for pain and inflammation treatment. Molecules, 2018, 23(10), 2478.
[2]
Velasco, G.; Hernández-Tiedra, S.; Dávila, D.; Lorente, M. The use of cannabinoids as anticancer agents. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2016, 64, 259-266.
[http://dx.doi.org/10.1016/j.pnpbp.2015.05.010] [PMID: 26071989]
[3]
Guzmán, M. Cannabinoids: potential anticancer agents. Nat. Rev. Cancer, 2003, 3(10), 745-755.
[http://dx.doi.org/10.1038/nrc1188] [PMID: 14570037]
[4]
Izzo, A.A.; Borrelli, F.; Capasso, R.; Di Marzo, V.; Mechoulam, R. Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb. In: Trends in Pharmacological Sciences; Elsevier Ltd, 2009, 30, pp. 515-527.
[5]
Bachari, A.; Piva, T.J.; Salami, S.A.; Jamshidi, N.; Mantri, N. Roles of cannabinoids in melanoma: Evidence from in vivo studies. Int. J. Mol. Sci., 2020, 21(17), E6040.
[http://dx.doi.org/10.3390/ijms21176040] [PMID: 32839414]
[6]
Casanova, M.L.; Blázquez, C.; Martínez-Palacio, J.; Villanueva, C.; Fernández-Aceñero, M.J.; Huffman, J.W.; Jorcano, J.L.; Guzmán, M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Invest., 2003, 111(1), 43-50.
[http://dx.doi.org/10.1172/JCI200316116] [PMID: 12511587]
[7]
Scheau, C.; Badarau, I.A.; Mihai, L.G.; Scheau, A.E.; Costache, D.O.; Constantin, C.; Calina, D.; Caruntu, C.; Costache, R.S.; Caruntu, A. Cannabinoids in the pathophysiology of skin inflammation. Molecules, 2020, 25(3), E652.
[http://dx.doi.org/10.3390/molecules25030652] [PMID: 32033005]
[8]
Armstrong, J.L.; Hill, D.S.; McKee, C.S.; Hernandez-Tiedra, S.; Lorente, M.; Lopez-Valero, I.; Eleni Anagnostou, M.; Babatunde, F.; Co-razzari, M.; Redfern, C.P.F.; Velasco, G.; Lovat, P.E. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J. Invest. Dermatol., 2015, 135(6), 1629-1637.
[http://dx.doi.org/10.1038/jid.2015.45] [PMID: 25674907]
[9]
Glodde, N.; Jakobs, M.; Bald, T.; Tüting, T.; Gaffal, E. Differential role of cannabinoids in the pathogenesis of skin cancer. Life Sci., 2015, 138, 35-40.
[http://dx.doi.org/10.1016/j.lfs.2015.04.003] [PMID: 25921771]
[10]
Kishi, P.; Price, C.J. Life-threatening reaction with topical 5-Fluorouracil. Drug Saf. Case Rep., 2018, 5(1), 4.
[http://dx.doi.org/10.1007/s40800-017-0068-6] [PMID: 29330682]
[11]
Wigmore, P.M.; Mustafa, S.; El-Beltagy, M.; Lyons, L.; Umka, J.; Bennett, G. Effects of 5-FU. Adv. Exp. Med. Biol., 2010, 678, 157-164.
[http://dx.doi.org/10.1007/978-1-4419-6306-2_20] [PMID: 20738018]
[12]
Imran, M.; Iqubal, M.K.; Ahmad, S.; Ali, J.; Baboota, S. Stability-indicating high-performance thin-layer chromatographic method for the simultaneous determination of quercetin and resveratrol in the lipid-based nanoformulation. J. Planar Chromatogr. Mod. TLC, 2019, 32(5), 393-400.
[http://dx.doi.org/10.1556/1006.2019.32.5.7]
[13]
Imran, M.; Iqubal, M.K.; Imtiyaz, K.; Saleem, S.; Mittal, S.; Rizvi, M.M.A.; Ali, J.; Baboota, S. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int. J. Pharm., 2020, 587, 119705.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119705] [PMID: 32738456]
[14]
Zafar, S.; Akhter, S.; Garg, N.; Selvapandiyan, A.; Kumar Jain, G.; Ahmad, F.J. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity. Eur. J. Pharm. Biopharm., 2020, 148, 10-26.
[http://dx.doi.org/10.1016/j.ejpb.2019.12.016] [PMID: 31923585]
[15]
Soliman, E.; Da, L.; Van Dross, R. Central cannabinoids as therapeutics for non-melanoma and melanoma skin cancer. J. Dermatology. Clin. Res., 2016, 4(2), 1069.
[16]
Williams, A.C. Topical 5-FU-a new approach to skin cancer. Ann. Surg., 1971, 173(6), 864-871.
[http://dx.doi.org/10.1097/00000658-197106010-00003] [PMID: 5578800]
[17]
Zivovinovic, S.; Alder, R.; Allenspach, M.D.; Steuer, C. Determination of cannabinoids in Cannabis sativa L. samples for recreational, medical, and forensic purposes by reversed-phase liquid chromatography-ultraviolet detection. J. Anal. Sci. Technol., 2018, 9(27), 1-9.
[http://dx.doi.org/10.1186/s40543-018-0159-8]
[18]
Pourseyed, L.M.; Torres, S.; Hooker, T.; Fowlie, C.; Young, O.; Seyfoddin, A. Methods for quantification of cannabinoids: A narrative review. J. Cannabis Res., 2020, 2(1), 1-10.
[19]
Nassim, M.A.; Shirazi, F.H.; Cripps, C.M.; Veerasinghan, S.; Molepo, M.J.; Obrocea, M.; Redmond, D.; Bates, S.; Fry, D.; Stewart, D.J.; Goel, R. An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yield. Int. J. Mol. Med., 2002, 10(4), 513-516.
[http://dx.doi.org/10.3892/ijmm.10.4.513] [PMID: 12239603]
[20]
Ciccolini, J.; Mercier, C.; Blachon, M.F.; Favre, R.; Durand, A.; Lacarelle, B. A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydro-genase (DPD) activity. J. Clin. Pharm. Ther., 2004, 29(4), 307-315.
[http://dx.doi.org/10.1111/j.1365-2710.2004.00569.x] [PMID: 15271097]
[21]
Semail, N.F.; Abdul Keyon, A.S.; Saad, B.; Noordin, S.S.; Nik Mohamed Kamal, N.N.S.; Mohamad Zain, N.N. Analytical method development and validation of anticancer agent, 5-fluorouracil, and its metabolites in biological matrices: An updated review. J. Liq. Chromatogr. Relat. Technol., 2020, ID: 221766264.
[http://dx.doi.org/10.1080/10826076.2020.1781654]
[22]
Mandrioli, M.; Tura, M.; Scotti, S.; Gallina Toschi, T. Fast detection of 10 cannabinoids by RP-HPLC-UV method in Cannabis sativa L. Molecules, 2019, 24(11), E2113.
[http://dx.doi.org/10.3390/molecules24112113] [PMID: 31167395]
[23]
Singh, A.; Ubrane, R.; Prasad, P.; Ramteke, S. Preparation and characterization of rizatriptan benzoate loaded solid lipid nanoparticles for brain targeting. Mater. Today Proc., 2015, 2(9), 4521-4543.
[http://dx.doi.org/10.1016/j.matpr.2015.10.067]
[24]
Aubin, A. Purification of cannabidiol from hemp oil using the prep150 LC system; Waters Corporation: Milford, MA, USA, 2015, pp. 1-5.
[25]
Wrightson, W.R.; Myers, S.R.; Galandiuk, S. HPLC analysis of 5-FU and FdUMP in tissue and serum. Biochem. Biophys. Res. Commun., 1995, 216(3), 808-813.
[http://dx.doi.org/10.1006/bbrc.1995.2693] [PMID: 7488197]
[26]
Nakagawa, K.; Umeda, T.; Higuchi, O.; Tsuzuki, T.; Suzuki, T.; Miyazawa, T. Evaporative light-scattering analysis of sulforaphane in broccoli samples: Quality of broccoli products regarding sulforaphane contents. J. Agric. Food Chem., 2006, 54(7), 2479-2483.
[http://dx.doi.org/10.1021/jf051823g] [PMID: 16569031]
[27]
Kumar, S.; Lather, V.; Pandita, D. Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma. Food Chem., 2016, 197(PtA), 959-964.
[http://dx.doi.org/10.1016/j.foodchem.2015.11.078] [PMID: 26617040]
[28]
Mangla, B.; Beg, S.; Alam, O.; Ahsan, W.; Haque, A.; Patel, K.S. Systematic development and validation of RP-HPLC method for simulta-neous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations. Arab. J. Chem., 2020, 13(11), 7909-7920.
[http://dx.doi.org/10.1016/j.arabjc.2020.09.022]
[29]
Dejaegher, B.; Heyden, Y.V. Ruggedness and robustness testing. J. Chromatogr. A, 2007, 1158(1-2), 138-157.
[http://dx.doi.org/10.1016/j.chroma.2007.02.086] [PMID: 17379230]
[30]
Zhang, H.; Wang, G.; Yang, H. Drug delivery systems for differential release in combination therapy. Expert Opin. Drug Deliv., 2011, 8(2), 171-190.
[http://dx.doi.org/10.1517/17425247.2011.547470] [PMID: 21226651]
[31]
Hasan, N.; Imran, M.; Kesharwani, P.; Khanna, K.; Karwasra, R.; Sharma, N.; Rawat, S.; Sharma, D.; Ahmad, F.J.; Jain, G.K.; Bhatnagar, A.; Talegaonkar, S. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int. J. Pharm., 2021, 599, 120428.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120428] [PMID: 33662465]
[32]
Khanna, K.; Sharma, N.; Rawat, S.; Khan, N.; Karwasra, R.; Hasan, N.; Kumar, A.; Jain, G.K.; Nishad, D.K.; Khanna, S.; Popli, H.; Bhatnagar, A. Intranasal solid lipid nanoparticles for management of pain: A full factorial design approach, characterization & Gamma Scintigraphy. Chem. Phys. Lipids, 2021, 236, 105060.
[http://dx.doi.org/10.1016/j.chemphyslip.2021.105060] [PMID: 33582127]
[33]
Ahmad, M.; Sharif, T.; Javed, A.A.; Zabta, M.; Jeelani, B. Alamgeer. Bioavailability study of oral 5-fluorouracil in colorectal cancer pa-tients. Pharmacologyonline, 2008, 2008(3), 100-109.
[34]
Sood, S.; Bala, R.; Gill, N.S. Method development and validation using HPLC technique – A review. J. Drug Discov. Ther., 2014, 2(22), 18-24.
[35]
Bhagyasree, T.; Injeti, N.; Azhakesan, A.; Rao, U.M.V. A review on analytical method development and validation. Int. J. Pharm. Res. Anal., 2014, 4(8), 444-448.
[36]
Toomula, N.; Kumar, A.; Kumar, S.D.; Bheemidi, V.S. Development and validation of analytical methods for pharmaceuticals. J. Anal. Bioanal. Tech., 2011, 2(5), 1-4.
[http://dx.doi.org/10.4172/2155-9872.1000127]

Rights & Permissions Print Cite
Article Metrics
26
1
© 2024 Bentham Science Publishers | Privacy Policy